Cargando…
Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases †
Fibromyalgia (FM) diagnosis follows the American College of Rheumatology (ACR) criteria, based on clinical evaluation and written questionnaires without any objective diagnostic tool. The lack of specific biomarkers is a tragic aspect for FM and chronic pain diseases in general. Interestingly, the e...
Autores principales: | Raffaeli, William, Malafoglia, Valentina, Bonci, Antonello, Tenti, Michael, Ilari, Sara, Gremigni, Paola, Iannuccelli, Cristina, Gioia, Chiara, Di Franco, Manuela, Mollace, Vincenzo, Vitiello, Laura, Tomino, Carlo, Muscoli, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073128/ https://www.ncbi.nlm.nih.gov/pubmed/32098316 http://dx.doi.org/10.3390/ijms21041499 |
Ejemplares similares
-
An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor’s Expression on NK Cells?
por: Malafoglia, Valentina, et al.
Publicado: (2023) -
The Interplay between Chronic Pain, Opioids, and the Immune
System
por: Malafoglia, Valentina, et al.
Publicado: (2021) -
Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis
por: Garofalo, Cinzia, et al.
Publicado: (2023) -
Chronic Pain: What Does It Mean? A Review on the Use of the Term Chronic Pain in Clinical Practice
por: Raffaeli, William, et al.
Publicado: (2021) -
A Review of the Clinical and Therapeutic Implications of Neuropathic Pain
por: Balzani, Eleonora, et al.
Publicado: (2021)